InvestorsHub Logo
Followers 1
Posts 36
Boards Moderated 0
Alias Born 11/16/2018

Re: None

Monday, 12/03/2018 8:57:54 AM

Monday, December 03, 2018 8:57:54 AM

Post# of 18784
I am holding all my shares of AEZS for the European approval of Macrilen which should happen next month and then buyout of AEZS or big licensing deal for Macrilen worldwide outside of North America which should happen in February 2019. I think that the price of AEZS could reach $4-$5 this month and then can reach $6-$8 in January upon Macrilen approval in Europe. I'm thinking that AEZS will be bought out by Novo Nordisk or other big pharma for $15-$18 per share in February 2019. These are just my opinions. Always do your own due diligence.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News